Health economic analysis by the Swedish Dental and Pharmaceutical Benefits Agency shows the cost-effectiveness of using the Coala Pro Cardiac Monitor in primary care

0

The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has, at the request of the Medical Technology Products Council (MTP), conducted a health economic analysis of Coala Heart Monitor Pro for remote monitoring and diagnosis of atrial fibrillation. The results have now been published by TLV with the conclusion that the use of Coala Heart Monitor Pro may provide greater benefit at lower cost with a saving of approximately SEK 606 at SEK 929 per examination compared to a 24-hour Holter ECG.

TLV’s valuation is based on a 2021 health economic analysis by Quantify Research, a consulting firm specializing in health economic surveys. The analysis compares the costs and benefits of Coala Heart Monitor Pro and 24-hour Holter in the Swedish healthcare setting. TLV concludes that Coala Heart Monitor Pro is economical and generates greater benefit for the patient by detecting symptoms to a greater extent and thus enables treatment to reduce the incidence/risk of stroke.

“The TLV assessment supports our analysis, and it is gratifying that these two panels of experts have come to the conclusion that Coala Heart Monitor Pro provides significant benefits to healthcare. Our patient-centric solution has the potential to reduce healthcare burden and shorten the wait time for atrial fibrillation investigation,” comments Dan Pitulia, CEO of Coala’s life.

“During the development of the model, we worked closely with clinical expertise to fill knowledge gaps where reliable data was limited and to ensure that the model reflected a real-world environment as accurately as possible. We also received feedback from primary care physicians who are already using Coala Heart Monitor Pro in their clinical practice, to adapt the model scenarios accordingly. We are therefore confident that our assessment, showing that Coala Heart Monitor Pro is a cost-effective alternative in Swedish primary care, is reliable,” explains Rosa Lauppeassociate director at Quantify Research and responsible for the analysis commissioned by Coala’s life.

Atrial fibrillation is the most common arrhythmia in adults. In Sweden alone, it is estimated that more than 300,000 people over the age of 20 have experienced symptoms of atrial fibrillation. About ten percent of SwedenThe population over the age of 80 is estimated to suffer from atrial fibrillation, and in all age groups, atrial fibrillation is more common in men than in women. It is estimated that around a third of all atrial fibrillations are silent and asymptomatic, which leads to difficulties in establishing a diagnosis and can lead to an increased risk of stroke. New medical technology solutions such as Coala Heart Monitor Pro offer healthcare providers a cost-effective tool with greater diagnostic accuracy for investigations of intermittent atrial fibrillation compared to conventional 24-hour Holter ECG.

The TLV report is available for download here.

Share.

Comments are closed.